Founder virus population related to route of virus transmission: A determinant of intrahost human immunodeficiency virus type 1 evolution?

Journal of Virology

Volumn 71, Issue 3, 1997, Pages 2023-2030

  Lukashov, Vladimir V ^a,b   Goudsmit, Jaap ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG USE; EVOLUTION; FOUNDER EFFECT; HOMOSEXUALITY; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; LYMPHOCYTE COUNT; MALE; NETHERLANDS; PHYLOGENY; PRIORITY JOURNAL; SEROCONVERSION; SEXUAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 0031041174     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.3.2023-2030.1997     Document Type: Article

References (41)

1. Adams, W. H., R. A. Rufo, L. Talarico, S. L. Silverman, and M. J. Brauer. 1978. Trombocytopenia and intravenous heroine use. Ann. Intern. Med. 89:207-211.
2. Barnett, S. W., A. Barboza, C. M. Wilcox, C. E. Forsmark, and J. A. Levy. 1991. Characterization of human immunodeficiency virus type 1 strains recovered from the bowel of infected individuals. Virology 182:802-809.
3. Blanck, R. R., N. Ream, and M. J. Deegan. 1980. Immunoglobulins in heroin users. Am. J. Epidemiol. 111:81-86.
4. Boom, R., C. J. A. Sol, M. M. M. Salimans, C. L. Jansen, P. M. E. Wertheimvan Dillen, and J. van der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
5. Brown, S. M., B. Stimmel, R. N. Taub, S. Kochwa, and R. E. Rosenfield. 1974. Immunologic dysfunction in heroin addicts. Arch. Intern. Med. 134: 1001-1006.
6. Chesebro, B., J. Nishio, S. Perryman, A. Cann, W. O'Brien, I. S. Y. Chen, and K. Wehrly. 1991. Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages. J. Virol. 65:5782-5789.
7. Chesebro, B., K. Wehrly, J. Nishio, and S. Perryman. 1992. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J. Virol. 66:6547-6554.
8. Delwart, E. L., H. W. Sheppard, B. D. Walker, J. Goudsmit, and J. I. Mullins. 1994. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J. Virol. 68:6672-6683.
9. de Wolf, F., E. Hogervorst, J. Goudsmit, E.-M. Fenyö, H. Rübsamen-Waigmann, H. Holmes, B. Galvao-Castro, E. Karita, C. Wasi, S. D. K. Sempala, E. Baan, F. Zorgdrager, V. Lukashov, S. Osmanov, C. Kuiken, M. Cornelissen, and WHO Network on HIV Isolation and Characterization. 1994. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. AIDS Res. Hum. Retroviruses 10:1387-1400.
10. Donahoe, R. M., J. K. Nicholson, J. J. Madden, F. Donahoe, D. A. Shafer, D. Gordon, P. Bokos, and A. Falek. 1986. Coordinate and independent effects of heroin, cocaine and alcohol abuse on T-cell E-rosette formation and antigenic marker expression. Clin. Immunol. Immunopathol. 41:254-264.
11. Duarte, E. A., D. K. Clarke, A. Moya, S. F. Elena, E. Domingo, and J. Holland. 1993. Many-trillionfold amplification of single RNA virus particles fails to overcome the Muller's ratchet effect. J. Virol. 67:3620-3623.
12. Felsenstein, J. 1990. Phylip manual version 3.2. University Herbarium, University of California, Berkeley, Calif.
13. Higgins, D. G. 1992. Sequence ordinations: a multivariate analysis approach to analysing large sequence data sets. CABIOS 8:15-22.
14. Kimura, M. 1981. Estimation of evolutionary distances between homologous nucleotide sequences. Proc. Natl. Acad. Sci. USA 78:454-458.
15. Korber, B., and G. Myers. 1992. Signature pattern analysis: a method for assessing viral sequence relatedness. AIDS Res. Hum. Retroviruses 8:1549-1560.
16. Kuiken, C. L., M. T. E. Cornelissen, F. Zorgdrager, S. Hartman, A. J. Gibbs, and J. Goudsmit. 1996. Consistent risk group-associated differences in human immunodeficiency virus type 1 vpr, vpu and V3 sequences despite independent evolution. J. Gen. Virol. 77:783-792.
17. Kuiken, C. L., and J. Goudsmit. 1994. Silent mutation pattern in V3 sequences distinguishes virus according to risk group in Europe. AIDS Res. Hum. Retroviruses 10:319-320.
18. Kuiken, C. L., V. V. Lukashov, E. Baan, J. Dekker, J. A. M. Leunissen, and J. Goudsmit. 1996. Evidence for limited within-person evolution of the V3 domain of the HIV-1 envelope in the Amsterdam population. AIDS 10:31-37.
19. Kuiken, C. L., G. Zwart, E. Baan, R. A. Coutinho, J. A. R. van den Hoek, and J. Goudsmit. 1993. Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic. Proc. Natl. Acad. Sci. USA 90:9061-9065.
20. Kumar, S., K. Tamura, and M. Nei. 1993. Molecular evolutionary genetics analysis (MEGA). Version 1.01. Institute of Molecular Evolutionary Genetics, Pennsylvania State University, University Park, Penn.
21. Lukashov, V. V. Unpublished data.
22. Lukashov, V. V., C. L. Kuiken, and J. Goudsmit. 1995. Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period. J. Virol. 69:6911-6916.
23. Lukashov, V. V., C. L. Kuiken, D. Vlahov, R. A. Coutinho, and J. Goudsmit. 1996. Evidence for HIV type 1 strains of U.S. intravenous drug users as founders of AIDS epidemic among intravenous drug users in Northern Europe. AIDS Res. Hum. Retroviruses 12:1179-1183.
24. McDonough, R. J., J. J. Madden, A. Falek, D. A. Shafer, M. Pline, D. Gordon, P. Bokos, J. C. Kuehnle, and J. Mendelson. 1980. Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on T lymphocytes. J. Immunol. 125:2539-2543.
25. Mehrishi, J. N., and I. H. Mills. 1983. Opiate receptors on lymphocytes and platelets in man. Clin. Immunol. Immunopathol. 27:240-249.
26. Mientjes, G. H., F. Miedema, E. J. van Ameijden, A. A. van den Hoek, P. T. A. Schellekens, M. T. Roos, and R. A. Coutinho. 1991. Frequent injecting impairs lymphocyte reactivity in HIV-positive and HIV-negative drug users. AIDS 5:35-41.
27. Mientjes, G. H. C., E. J. C. van Ameijden, A. J. A. R. van den Hoek, J. Goudsmit, F. Miedema, and R. A. Coutinho. 1993. Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injection equipment. AIDS 7:1363-1370.
28. Mientjes, G. H. C., E. J. C. van Ameijden, H. M. Weigel, J. A. R. van den Hoek, and R. A. Coutinho. 1993. Clinical symptoms associated with HIV-1 seroconversion among intravenous drug users: a comparison with homosexual seroconvertors, HIV-1 infected and non-infected intravenous drug users. Br. Med J. 306:371-373.
29. Munoz, A., D. Vlahov, L. Solomon, J. B. Margolick, J. C. Bareta, S. Cohn, J. Astemborski, and K. E. Nelson. 1992. Prognostic indicators for development of AIDS among intravenous drug users. J. Acquired Immune Defic. Syndr. 5:694-700.
30. Novella, I. S., E. A. Duarte, S. F. Elena, A. Moya, E. Domingo, and J. J. Holland. 1995. Exponential increases of RNA virus fitness during large population transmissions. Proc. Natl. Acad. Sci. USA 92:5841-5844.
31. Selwyn, P. A., P. Alcabes, D. Hartel, D. Buono, E. E. Schoenbaum, K. S. Klein, K. Davenny, and G. H. Friedland. 1992. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N. Engl. J. Med. 327:1697-1703.
32. Spijkerman, I. J. B., M. Koot, M. Prins, I. P. M. Keet, A. J. A. R. van den Hoek, F. Miedema, and R. A. Coutinho. 1995. Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men. AIDS 9:1085-1092.
33. van der Hoek, L., R. Boom, J. Goudsmit, F. Snijders, and C. J. A. Sol. 1995. Isolation of human immunodeficiency virus type 1 (HIV-1) RNA from feces by a simple method and difference between HIV-1 subpopulations in feces and serum. J. Clin. Microbiol. 33:581-588.
34. van der Hoek, L., C. J. A. Sol, F. Snijders, J. F. W. Bartelsman, R. Boom, and J. Goudsmit. 1996. Human immunodeficiency virus type 1 RNA populations in faeces with higher homology to intestinal populations than to blood populations. J. Gen. Virol. 77:2415-2425.
35. van Gemen, B., R. van Beuningen, A. Nabbe, D. van Strijp, S. Jurriaans, P. Lens, and T. Kievits. 1994. A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes. J. Virol. Methods 49:157-168.
36. Wetli, C. V., T. A. Noto, and A. F. Carol. 1974. Immunologic abnormalities in heroin addiction. South. Med. J. 67:193-197.
37. Wolfs, T. F. W., J. J. de Jong, H. Van den Berg, J. M. G. H. Tijnagel, W. J. A. Krone, and J. Goudsmit. 1990. Evolution of sequences encoding the principal neutralization epitope of HIV-1 is host-dependent, rapid and continuous. Proc. Natl. Acad. Sci. USA 87:9938-9942.
38. Wolinsky, S. M., B. T. M. Korber, A. U. Neumann, M. Daniels, K. J. Kunstman, A. J. Whetsell, M. R. Furtado, Y. Z. Cao, D. D. Ho, J. T. Safrit, and R. A. Koup. 1996. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537-542.
39. Wybran, J., T. Appelboom, J. P. Famaey, and A. Govaerts. 1979. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J. Immunol. 123:1068-1070.
40. Zhu, T., H. Mo, N. Wang, D. S. Nam, Y. Cao, R. A. Koup, and D. D. Ho. 1993. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261:1179-1181.
41. Zhu, T., N. Wang, A. Carr, D. S. Nam, R. Moor-Jankowski, D. A. Cooper, and D. D. Ho. 1996. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J. Virol. 70:3098-3107.